ACT (81)

Report your review integrity concerns. Report your concerns about unfair review. Learn more about integrity & fairness in review.

Special Emphasis Panel for Cancer Therapeutics – ACT (81)

Image
Dr. Michael Opata

Dr. Michael Opata

Scientific Review Officer

Applications investigating the mechanisms-of-action of cancer therapies across drug classes encompassing established or repurposed cancer therapeutics. Studies focused on systems level translational modeling, drug synergy and therapeutic efficacy.

Review Dates

Topics

  • Evaluation of the mechanism of action of established or repurposed cancer therapeutics spanning small molecules, peptide, protein, cellular, and genetic experimental therapeutics.
  • Impact of drug treatments and combinations on epigenetic regulation, RNA processing, and post-translational modification.
  • systems level translational modeling, including mathematical and computational methods for the investigation of therapeutic strategies.

Discover Other Possible Study Sections

Return to Top